Companies Special Situations Explorer About

TEXAS INSTRUMENT INC (TXN)

Sector: Information Technology

Ticker	Position	Age	Qualifications and Experience	Committee Memberships	Filing Year

Carrie S. Cox

Director information for TXN

Ticker	Position	Age	Qualifications and Experience	Committee Memberships	Filing Year
TXN	Former chairman and chief executive officer of Humacyte, Inc.	68	["Management responsibility of a large multinational company operating in a regulated industry","Responsibility for significant capital and R&D investments"]	[]	2026

Other possible board matches

Companies shown below are based on exact name match for the selected Director

Ticker	Position	Age	Qualifications and Experience	Committee Memberships	Filing Year
OGN	Executive Chair of the Board; Chairman of the Board	68	["Executive Chair of Organon & Co.","Former Chief Executive Officer of Humacyte, Inc.","Former EVP of Schering-Plough","Current Chairman of Solventum Corporation","Director of Texas Instruments Inc.","Chief Executive Officer of Humacyte, Inc. (2010-2018)","Chairman of Humacyte's board (2013-2019)","Executive Vice President of Schering-Plough Corporation (2003-2009)","President of Schering-Plough’s global pharmaceutical business (2003-2009)","President of Pharmacia Corporation's global pharmaceutical business (1997-2003)","Chairman of the board of directors of Solventum Corporation"]	[]	2026
SOLV	Chair of the Board; Chair of the board	68	["Former Chief Executive Officer, Humacyte, Inc.", "30 years of experience in leadership roles and member of multiple boards at healthcare companies", "Pharmaceutical and biotech executive experience including as CEO of a regenerative medicine company", "Significant experience as a seasoned executive and audit committee member", "Service on the boards and senior executive roles at global healthcare companies", "Deep experience in guiding companies undergoing significant transitions, including recently spun-off companies, as well as in M&A transactions", "Deep experience at head of drug and biotech development companies; Responsible for significant capital and R&D investments", "Management responsibility of a large multinational company operating in a regulated industry", "Roles including oversight of sales plans, marketing and brand for large global companies", "Significant experience as chair of board at multiple public and private companies with oversight over risk", "Notable compensation committee expertise"]	["TC", "STQC", "Talent", "Science, Technology and Quality"]	2026
CAH	Chair of the Human Resources and Compensation Committee		[]	["Human Resources and Compensation Committee", "Governance and Sustainability Committee"]	2023